Dendreon Volume and Volatility Compress Ahead of ASCO
by Jon C. Ogg
24/7 Wall St.
If you thought the day would never come that Dendreon (DNDN) would see its volatility, its hyperactive volume, and its options premium compress to something back to almost normal, guess again: it came. The stock including after-hours only traded under 5.5 million shares. The near-month June options have seen the volume dry up, and the closest call options (JUN07 $7.50 Calls) are only priced at $0.25. That is unheard of, yet this is just getting back to normal. Even its stock only saw a $0.30 trading band between the highs and the lows.
Its MAY short interest showed it to be relatively high earlier in month, but that cut-off date was before even last week. Just a week ago the stock was getting a lot of volume and interest because of some AUA data presentation (which is actually older 're-analyzed' data) and after the cost cutting and impending layoffs.
Continue article at 247WallSt.com
RELATED READING:
- Cancer Stocks on the Go: It’s ASCO
- Dendreon Interest Remains Extremely High
_____________________
24/7 Wall St.
If you thought the day would never come that Dendreon (DNDN) would see its volatility, its hyperactive volume, and its options premium compress to something back to almost normal, guess again: it came. The stock including after-hours only traded under 5.5 million shares. The near-month June options have seen the volume dry up, and the closest call options (JUN07 $7.50 Calls) are only priced at $0.25. That is unheard of, yet this is just getting back to normal. Even its stock only saw a $0.30 trading band between the highs and the lows.
Its MAY short interest showed it to be relatively high earlier in month, but that cut-off date was before even last week. Just a week ago the stock was getting a lot of volume and interest because of some AUA data presentation (which is actually older 're-analyzed' data) and after the cost cutting and impending layoffs.
Continue article at 247WallSt.com
RELATED READING:
- Cancer Stocks on the Go: It’s ASCO
- Dendreon Interest Remains Extremely High
_____________________
posted by Nico at
8:55 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home